In an article in the Annals of Oncology, Ian Tannock and colleagues from Princess Margaret Hospital in Toronto report on the tendency of investigators to underreport the side effects of chemotherapy in randomized clinical trials in breast cancer with positive results. Read more here.
Study mentioned: Vera-Badillo FE, et al. Bias in reporting of end points of efficacy and toxicity in randomized, clinical trials for women with breast cancer. Ann Oncol. 2013 Jan 9. [Epub ahead of print] PMID: 23303339
No comments:
Post a Comment